Congenica Tries To Bring Clarity To Personalized Medicine For Rare Diseases
Executive Summary
Medtech Insight spoke to David Atkins, the CEO of genomics company Congenica, to learn more about how its platform is being used in one of the largest genetics studies to date. The company expects the technology to eventually transform treatment of rare diseases.